Post-transplant lymphoproliferative disorder, early lesion (Q39453): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Revision as of 04:52, 13 August 2026
A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterised by the lack of tissue destruction and the architectural preservation of the involved tissues. It includes two morphologic variants: plasmacytic hyperplasia and infectious mononucleosis-like lymphoproliferative disorders.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2B32.0 |
||
| English | Post-transplant lymphoproliferative disorder, early lesion |
A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterised by the lack of tissue destruction and the architectural preservation of the involved tissues. It includes two morphologic variants: plasmacytic hyperplasia and infectious mononucleosis-like lymphoproliferative disorders. |
Statements
CID11:2B32.0
0 references
dki-india-2B32.0
0 references
Concluído
0 references
13 August 2026
0 references
